Free Trial

Alyeska Investment Group L.P. Buys 422,410 Shares of The Sherwin-Williams Company $SHW

Sherwin-Williams logo with Basic Materials background

Key Points

  • Alyeska Investment Group L.P. has increased its holdings in Sherwin-Williams by 367.9% in the first quarter, acquiring an additional 422,410 shares, bringing its total ownership to 537,216 shares valued at approximately $187.6 million.
  • Sherwin-Williams recently reported earnings of $3.38 per share for the quarter, falling short of analysts' expectations, and set its FY 2025 guidance at 11.200-11.500 EPS.
  • The company declared a quarterly dividend of $0.79 per share, scheduled for payment on September 5th, representing a 0.9% yield based on its current stock price.
  • Five stocks we like better than Sherwin-Williams.

Alyeska Investment Group L.P. grew its holdings in The Sherwin-Williams Company (NYSE:SHW - Free Report) by 367.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 537,216 shares of the specialty chemicals company's stock after acquiring an additional 422,410 shares during the quarter. Sherwin-Williams accounts for about 0.7% of Alyeska Investment Group L.P.'s investment portfolio, making the stock its 27th largest holding. Alyeska Investment Group L.P. owned about 0.21% of Sherwin-Williams worth $187,590,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Vanguard Group Inc. lifted its stake in shares of Sherwin-Williams by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 22,082,544 shares of the specialty chemicals company's stock valued at $7,711,004,000 after acquiring an additional 245,896 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Sherwin-Williams by 21.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,657,536 shares of the specialty chemicals company's stock valued at $3,023,126,000 after acquiring an additional 1,505,341 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Sherwin-Williams by 6.5% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,826,498 shares of the specialty chemicals company's stock valued at $620,881,000 after purchasing an additional 111,128 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Sherwin-Williams by 41,717.1% during the 1st quarter. GAMMA Investing LLC now owns 1,636,304 shares of the specialty chemicals company's stock valued at $571,381,000 after acquiring an additional 1,632,391 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Sherwin-Williams by 4.4% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,536,398 shares of the specialty chemicals company's stock valued at $536,495,000 after acquiring an additional 64,325 shares during the last quarter. Institutional investors own 77.67% of the company's stock.

Sherwin-Williams Stock Performance

Shares of NYSE:SHW traded down $0.16 during trading on Monday, hitting $372.27. The stock had a trading volume of 514,113 shares, compared to its average volume of 1,790,526. The company has a quick ratio of 0.48, a current ratio of 0.78 and a debt-to-equity ratio of 1.78. The stock has a 50-day simple moving average of $352.81 and a two-hundred day simple moving average of $348.64. The Sherwin-Williams Company has a 12-month low of $308.84 and a 12-month high of $400.42. The stock has a market capitalization of $92.82 billion, a price-to-earnings ratio of 36.95, a price-to-earnings-growth ratio of 3.09 and a beta of 1.18.

Sherwin-Williams (NYSE:SHW - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The specialty chemicals company reported $3.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.76 by ($0.38). Sherwin-Williams had a net margin of 11.03% and a return on equity of 66.91%. The company had revenue of $6.31 billion for the quarter, compared to analysts' expectations of $6.31 billion. During the same period in the previous year, the business earned $3.70 earnings per share. The business's revenue for the quarter was up .6% on a year-over-year basis. Sherwin-Williams has set its FY 2025 guidance at 11.200-11.500 EPS. On average, equities research analysts expect that The Sherwin-Williams Company will post 12 earnings per share for the current fiscal year.

Sherwin-Williams Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 15th were given a $0.79 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $3.16 dividend on an annualized basis and a yield of 0.8%. Sherwin-Williams's payout ratio is 31.35%.

Insiders Place Their Bets

In other Sherwin-Williams news, insider Justin T. Binns sold 609 shares of the firm's stock in a transaction on Monday, August 25th. The shares were sold at an average price of $368.82, for a total transaction of $224,611.38. Following the transaction, the insider directly owned 17,922 shares of the company's stock, valued at approximately $6,609,992.04. This trade represents a 3.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO James P. Lang sold 860 shares of Sherwin-Williams stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $350.35, for a total value of $301,301.00. Following the transaction, the chief accounting officer directly owned 377 shares of the company's stock, valued at $132,081.95. This trade represents a 69.52% decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on SHW shares. UBS Group cut their target price on Sherwin-Williams from $410.00 to $395.00 and set a "buy" rating on the stock in a research note on Wednesday, July 23rd. Wells Fargo & Company cut their price target on shares of Sherwin-Williams from $420.00 to $400.00 and set an "overweight" rating on the stock in a report on Wednesday, July 23rd. BMO Capital Markets lowered their target price on shares of Sherwin-Williams from $405.00 to $391.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 23rd. Mizuho cut their price target on Sherwin-Williams from $400.00 to $385.00 and set an "outperform" rating for the company in a research note on Wednesday, July 23rd. Finally, Citigroup decreased their price objective on Sherwin-Williams from $385.00 to $375.00 and set a "neutral" rating on the stock in a research note on Wednesday, July 23rd. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $387.27.

Get Our Latest Stock Report on SHW

About Sherwin-Williams

(Free Report)

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.

Read More

Institutional Ownership by Quarter for Sherwin-Williams (NYSE:SHW)

Should You Invest $1,000 in Sherwin-Williams Right Now?

Before you consider Sherwin-Williams, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.

While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.